Andrew Krueger, Research Investigator
Ben Taft, Research Investigator III - Infectious Disease
Job Openings at Novartis:
Deadline to Apply:
Friday, June 16th at 11:59 PM
The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis committed to discovering innovative medicines to treat diseases with high unmet medical need. With more than 6,000 scientists and physicians around the world, our open and entrepreneurial culture encourages collaboration as we work to push the boundaries of science to change the practice of medicine. NIBR takes a unique approach to pharmaceutical research. At the earliest stages, research priorities are determined by patient need and disease understanding. Scientists and physicians at NIBR have broken down the boundaries between research and clinical practice and collaborate at the earliest stages of the R&D process. We believe we can better answer the demand for safer, more effective medicines by keeping our sights on both the science and the patient. To do this we use Proof-of-Concept (PoC) clinical trials, small-scale studies in well-defined patient groups used to get an early read-out on a drug’s safety and effectiveness. These studies help us find and advance the most promising drug candidates.
For a current list of upcoming information sessions hosted by the Department of Chemistry, please click on the following link.